Showing results (281-290 of 335) with videos related to

Sort By:
Pageof 34
British Journal of Cancer|December 12, 2018
A phase 2 randomised study of veliparib plus FOLFIRI±bevacizumab versus placebo plus FOLFIRI±bevacizumab in metastatic colorectal cancerVera Gorbunova, J Thaddeus Beck, Ralf-Dieter Hofheinz, et al.
Cancer Chemotherapy and Pharmacology|February 22, 2005
Phase I study of weekly (day 1 and 8) docetaxel in combination with capecitabine in patients with advanced solid malignanciesRamesh K Ramanathan, Sakkaraiappan Ramalingam, Merrill J Egorin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2007
Dose-escalating and pharmacologic study of oxaliplatin in adult cancer patients with impaired hepatic function: a National Cancer Institute Organ Dysfunction Working Group studyTimothy W Synold, Chris H Takimoto, James H Doroshow, et al.
JAMA Oncology|April 19, 2019
Gemcitabine, Cisplatin, and nab-Paclitaxel for the Treatment of Advanced Biliary Tract Cancers: A Phase 2 Clinical TrialRachna T Shroff, Milind M Javle, Lianchun Xiao, et al.
Annals of the Rheumatic Diseases|April 7, 2007
Cardiovascular outcomes in high risk patients with osteoarthritis treated with ibuprofen, naproxen or lumiracoxibM E Farkouh, J D Greenberg, R V Jeger, et al.
Molecular Cancer Therapeutics|July 28, 2021
Phase I Open-Label Study Evaluating the Safety, Pharmacokinetics, and Preliminary Efficacy of Dilpacimab in Patients with Advanced Solid TumorsMichael S Gordon, John Nemunaitis, Minal Barve, et al.
British Journal of Cancer|July 20, 2017
Clinical study of genomic drivers in pancreatic ductal adenocarcinomaMichael T Barrett, Ray Deiotte, Elizabeth Lenkiewicz, et al.
The Oncologist|January 18, 2007
The continuum of care: a paradigm for the management of metastatic colorectal cancerRichard M Goldberg, Mace L Rothenberg, Eric Van Cutsem, et al.
Cancer Discovery|March 1, 2017
Phase I, Dose-Escalation, Two-Part Trial of the PARP Inhibitor Talazoparib in Patients with Advanced Germline BRCA1/2 Mutations and Selected Sporadic CancersJohann de Bono, Ramesh K Ramanathan, Lida Mina, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2017
Correlation between Ferumoxytol Uptake in Tumor Lesions by MRI and Response to Nanoliposomal Irinotecan in Patients with Advanced Solid Tumors: A Pilot StudyRamesh K Ramanathan, Ronald L Korn, Natarajan Raghunand, et al.
Pageof 34